# EDGAR Filing Document

**Accession Number:** 0001613103
**File Stem:** 0002137804-26-000002
**Filing Date:** 2026-6
**Character Count:** 7948
**Document Hash:** af8d5b63f4eac4bb2ee074536e22698a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002137804-26-000002.hdr.sgml**: 20260626

**ACCESSION NUMBER**: 0002137804-26-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260618

**FILED AS OF DATE**: 20260626

**DATE AS OF CHANGE**: 20260626

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Thompson Kweli
- **CENTRAL INDEX KEY:** 0002137804

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36820
- **FILM NUMBER:** 261129741

**MAIL ADDRESS:**
- **STREET 1:** 710 MEDTRONIC PARKWAY NE
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55432
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medtronic plc
- **CENTRAL INDEX KEY:** 0001613103
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **FISCAL YEAR END:** 0424

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING TWO PARKMORE BUSINESS PARK WEST
- **CITY:** GALWAY
- **PROVINCE COUNTRY:** L2
- **ZIP:** H91 4K49
- **BUSINESS PHONE:** 01135314381700

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING TWO PARKMORE BUSINESS PARK WEST
- **CITY:** GALWAY
- **PROVINCE COUNTRY:** L2
- **ZIP:** H91 4K49

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Medtronic Ltd
- **DATE OF NAME CHANGE:** 20150112

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Medtronic Holdings Ltd
- **DATE OF NAME CHANGE:** 20140711

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Kalani I Ltd
- **DATE OF NAME CHANGE:** 20140709

## Ex-24

![](kwelithompson-powerofatt001.jpg)

------

![](kwelithompson-powerofatt002.jpg)

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Thompson Kweli<br><sub>(Last) (First) (Middle)</sub><br>710 MEDTRONIC PARKWAY<br><sub>(Street)</sub><br>MINNEAPOLIS, MN 55432<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Medtronic plc [ MDT ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-06-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_EVP & President, Neuroscience_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 30017.737<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Performance Share Unit | <sup>(2)</sup> | <sup>(2)</sup> | Ordinary Shares | 3252.987<sup>(3)</sup> | <sup>(4)</sup> | D |  |
| Performance Share Units | <sup>(5)</sup> | <sup>(5)</sup> | Ordinary Shares | 9911.187<sup>(6)</sup> | <sup>(4)</sup> | D |  |
| Performance Share Units | <sup>(7)</sup> | <sup>(7)</sup> | Ordinary Shares | 9178.809<sup>(8)</sup> | <sup>(4)</sup> | D |  |
| Stock Option (Right to Buy) | 2017-08-01<sup>(9)</sup> | 2026-08-01 | Ordinary Shares | 1704 | $88.06 | D |  |
| Stock Option (Right to Buy) | 2018-01-30<sup>(9)</sup> | 2027-01-30 | Ordinary Shares | 1608 | $74.67 | D |  |
| Stock Option (Right to Buy) | 2018-07-31<sup>(9)</sup> | 2027-07-31 | Ordinary Shares | 4407 | $83.97 | D |  |
| Stock Option (Right to Buy) | 2019-07-30<sup>(9)</sup> | 2028-07-30 | Ordinary Shares | 6271 | $89.08 | D |  |
| Stock Option (Right to Buy) | 2020-07-29<sup>(9)</sup> | 2029-07-29 | Ordinary Shares | 1615 | $103.26 | D |  |
| Stock Option (Right to Buy) | 2021-08-03<sup>(9)</sup> | 2030-08-03 | Ordinary Shares | 10181 | $97.33 | D |  |
| Stock Option (Right to Buy) | 2022-08-02<sup>(9)</sup> | 2031-08-02 | Ordinary Shares | 6358 | $131.26 | D |  |
| Stock Option (Right to Buy) | 2023-08-01<sup>(9)</sup> | 2032-08-01 | Ordinary Shares | 26890 | $93.08 | D |  |
| Stock Option (Right to Buy) | 2024-07-31<sup>(9)</sup> | 2033-07-31 | Ordinary Shares | 25408 | $87.76 | D |  |
| Stock Option (Right to Buy) | 2025-07-29<sup>(9)</sup> | 2034-07-29 | Ordinary Shares | 1540 | $80 | D |  |
| Stock Option (Right to Buy) | 2026-07-28<sup>(9)</sup> | 2035-07-28 | Ordinary Shares | 22363 | $91.97 | D |  |

---

### Footnotes:

(1) Includes 6,549 performance stock units that vested on April 24, 2026; 1,822 restricted stock units that vested on December 6, 2025; 3,742.990 restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026; 9,911.187 restricted stock units that vest on July 29, 2027; 4,589.916 restricted stock units that vest on July 28, 2028.

(2) The performance share units ("PSUs") vest on December 6, 2026.

(3) The number of shares to be issued in connection with the PSUs reported reflects the amount earned based on achievement of applicable performance criteria. The award remains subject to time-based vesting.

(4) Each PSU represents a contingent right to receive one share of Medtronic common stock.

(5) The PSUs vest on April 30, 2027.

(6) The number of shares to be issued in connection with PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,911.187 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

(7) The PSUs vest on April 28, 2028.

(8) The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,178.809 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

(9) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

**Signature:** /s/ Patricia Walesiewicz, attorney-in-fact  
**Date:** 2026-06-26

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**